A biological pharmacology network to secure the risk of drug-drug interaction with nirmatrelvir/ritonavir

被引：0

作者：

Lemaitre, F. ^{[1
]}

Boland, L. ^{[2
]}

Tron, C. ^{[1
]}

Ruelland, A. L. ^{[3
]}

Lelong-Boulouard, V. ^{[4
]}

Baklouti, S. ^{[5
]}

Goirand, F. ^{[6
]}

Gambier, N. ^{[7
,8
]}

Boglione-Kerrien, C. ^{[1
]}

Franck, B. ^{[1
]}

Lalanne, S. ^{[1
]}

Devresse, A. ^{[9
]}

Briol, S. ^{[9
]}

De Greef, J. ^{[10
]}

Haufroid, V. ^{[2
]}

Verdier, M. ^{[1
]}

机构：

[1] Univ Rennes, IRSET Inst Rech Sante Environm & Travail, CHU Rennes, INSERM,EHESP,UMR S 1085, Rennes, France

[2] Uclouvain, Clin Univ St Luc, Dept Clin Chem, Brussels, Belgium

[3] Inst Biol, Dept Clin Pharmacol, Nantes, France

[4] Ctr Hosp Univ Caen Normandie, Serv Pharmacol, Ave Cote Nacre, Caen, France

[5] Hop Purpan, Lab Pharmacocinet & Toxicol, IFB, 330 Ave Grande Bretagne, Toulouse, France

[6] CHU Dijon, Lab Pharmacol Toxicol, Dijon, France

[7] Univ Lorraine, CNRS, IMOPA, F-54000 Nancy, France

[8] CHRU Nancy Brabois, Lab Pharmacol Toxicol Pharmacovigilance & Ceipa, Batiment Biol Med & Biopathol, 5 Rue Morvan Vandoeuvre Les, Nancy, France

[9] Uclouvain, Clin Univ St Luc, Dept Nephrol, Brussels, Belgium

[10] Uclouvain, Clin Univ St Luc, Dept Internal Med & Infect Dis, Brussels, Belgium

来源：

FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2023年 / 37卷

关键词：

metabolism; pharmacokinetics; therapeutic drug monitoring;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PM1-019

引用

页码：58 / 59

页数：2

共 50 条

[1] Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin
Sindelar, Morganne
McCabe, Daniel
Carroll, Elisabeth
JOURNAL OF MEDICAL TOXICOLOGY, 2023, 19 (01) : 45 - 48
[2] Experience of a nirmatrelvir/ritonavir drug-drug interaction expert advice service
Lemaitre, Florian
Tron, Camille
Lalanne, Sebastien
Franck, Benedicte
Boglione-Kerrien, Christelle
Taieb, Fabrice
Verdier, Marie-Clemence
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 : 6 - 7
[3] Pharmacovigilance of Drug-Drug Interactions with Nirmatrelvir/Ritonavir
Hendrick, Victoria
Pohorylo, Erast
Merchant, Lubna
Gerhart, Jackie
Arham, Iqra Naz
Draica, Florin
Quercia, Romina
Ayoub, Ayman
Mehta, Reema
INFECTIOUS DISEASES AND THERAPY, 2024, 13 (12) : 2545 - 2561
[4] Nirmatrelvir/ritonavir: real world drug-drug interaction management experience
Bukhari, Shahid
Hughes, Stephen
Mughal, Nabeela
Moore, Luke S. P.
Davies, Gary
Zhang, Adrian Varghas
Ng, Megan
Karagozlu, Zekiye
Boffito, Marta
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (09) : 781 - 783
[5] Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin"
de Oliveira, Luciana Mello
Dal Pizzol, Tatiane da Silva
JOURNAL OF MEDICAL TOXICOLOGY, 2023, 19 (03) : 307 - 308
[6] Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”
Luciana Mello de Oliveira
Tatiane da Silva Dal Pizzol
Journal of Medical Toxicology, 2023, 19 : 307 - 308
[7] Response to Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”
Morganne Sindelar
Daniel McCabe
Elisabeth Carroll
Journal of Medical Toxicology, 2023, 19 : 309 - 309
[8] Nirmatrelvir+ritonavir/tacrolimusDiarrhoea following drug-drug pharmacokinetic interaction: case report
Reactions Weekly, 2023, 1979 (1) : 349 - 349
[9] Response to Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin"
Sindelar, Morganne
McCabe, Daniel
Carroll, Elisabeth
JOURNAL OF MEDICAL TOXICOLOGY, 2023, 19 (03) : 309 - 309
[10] Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients
Xu, Xueyin
Zhang, Huanxi
Liu, Longshan
Fu, Qian
Wu, Chenglin
Lin, Xiaobin
Tang, Kejing
Wang, Changxi
Chen, Pan
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (08) : 1219 - 1227

← 1 2 3 4 5 →